Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville.
Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis.
J Manag Care Spec Pharm. 2021 Jan;27(1):105-111. doi: 10.18553/jmcp.2021.27.1.105.
Measuring patient perspectives of the quality of health care delivery is an essential component of building a patient-centered model of care, which has garnered increasing emphasis under value-based payment models. Although measurements of patient perspectives of physician practices are common, few validated measures are currently available to assess patient perspectives of pharmacy quality. To assess the reliability and validity of a brief measure that assesses patient experiences with the quality of community pharmacy services, referred to as the "patient experience" measure. This article focuses on the second phase of a 2-phase survey development study. In the second phase, a convenience sample of 400 adult patients with chronic health conditions completed the final 7-item version of the patient experience measure via an online survey. An exploratory factor analysis was performed to determine the number of factors underlying the patient experience measure. Internal consistency reliability was assessed with Cronbach's alpha, and construct validity was evaluated by examining relationships between the patient experience measure, a quality of pharmacy services item, and patient demographic variables. Eigenvalues and scree plots suggested a 1-factor solution, with this single factor explaining 64% of the variance in the patient experience measure. Cronbach's alpha indicated excellent reliability (α = 0.90). Individuals with more positive patient experience scores rated the quality of their pharmacies' services significantly higher (Pearson r = 0.73, < 0.001). Mean patient experience scores for those who had gone to their pharmacies for 7-11 months (mean = 3.66) were significantly lower than for those who had been going to their pharmacies for 5 or more years (mean = 4.22). The patient experience measure demonstrated excellent reliability and was correlated with patient perceptions of pharmacy quality. The measure also differentiated between individuals based on the length of time they had been going to their pharmacies. The scale could be used to quickly assess patient experience with community pharmacy services. This work was supported by the National Community Pharmacists Association Innovation Center through a grant from the Community Pharmacy Foundation. Farley reports an unrelated grant from AstraZeneca and fees from Takeda for expert testimony. The other authors have nothing to disclose. This work was presented as a virtual poster at the American Pharmacists Association (APhA) Annual Meeting & Exposition, March 2020, Washington, DC.
衡量患者对医疗服务提供质量的看法是建立以患者为中心的医疗模式的重要组成部分，这种模式在基于价值的支付模式下受到越来越多的重视。尽管对医生实践的患者观点的测量很常见，但目前很少有经过验证的措施可用于评估患者对药房质量的看法。为了评估一种评估社区药房服务质量患者体验的简短措施的可靠性和有效性，称为“患者体验”措施。本文重点介绍了一项 2 阶段调查开发研究的第二阶段。在第二阶段，通过在线调查，对 400 名患有慢性健康状况的成年患者进行了便利抽样，完成了患者体验措施的最终 7 项版本。进行了探索性因素分析，以确定患者体验措施的潜在因素数量。使用 Cronbach 的 alpha 评估内部一致性可靠性，并通过检查患者体验措施、药房服务质量项目与患者人口统计学变量之间的关系来评估结构有效性。特征值和碎石图表明存在 1 个因素解决方案，该单一因素解释了患者体验措施中 64%的方差。Cronbach 的 alpha 表示可靠性非常高（α=0.90）。患者体验得分较高的患者对其药房服务质量的评价明显更高（Pearson r=0.73，<0.001）。过去 7-11 个月去药房的患者的平均患者体验得分（均值=3.66）明显低于过去 5 年以上一直去药房的患者（均值=4.22）。患者体验措施具有良好的可靠性，并与患者对药房质量的看法相关。该措施还根据患者去药房的时间长短来区分个体。该量表可用于快速评估社区药房服务的患者体验。这项工作得到了国家社区药剂师协会创新中心的支持，该中心通过社区药剂师基金会的拨款获得资助。Farley 报告说，他还从 AstraZeneca 获得了一项无关的资助，并因专家证言从 Takeda 获得了报酬。其他作者没有任何要披露的内容。这项工作在 2020 年 3 月于华盛顿特区举行的美国药剂师协会（APhA）年会和博览会上作为虚拟海报展示。
